Wrapmanager Inc Guardant Health, Inc. Transaction History

Wrapmanager Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$43.66 - $61.0 $18,162 - $25,376	-416 Reduced 6.87%	5,643 $304,000
Q2 2022 Aug 05, 2022	SELL	$28.82 - $77.35 $3,487 - $9,359	-121 Reduced 1.96%	6,059 $244,000
Q1 2022 May 10, 2022	BUY	$48.25 - $100.49 $8,781 - $18,289	182 Added 3.03%	6,180 $409,000
Q4 2021 Feb 07, 2022	SELL	$88.71 - $120.43 $45,863 - $62,262	-517 Reduced 7.94%	5,998 $600,000
Q3 2021 Nov 10, 2021	SELL	$98.77 - $132.17 $9,185 - $12,291	-93 Reduced 1.41%	6,515 $814,000
Q2 2021 Aug 04, 2021	BUY	$109.77 - $165.68 $118,332 - $178,603	1,078 Added 19.49%	6,608 $821,000
Q1 2021 May 10, 2021	SELL	$127.04 - $179.1 $11,052 - $15,581	-87 Reduced 1.55%	5,530 $844,000
Q4 2020 Feb 08, 2021	SELL	$99.96 - $135.93 $6,497 - $8,835	-65 Reduced 1.14%	5,617 $724,000
Q3 2020 Nov 12, 2020	SELL	$80.32 - $111.8 $7,228 - $10,062	-90 Reduced 1.56%	5,682 $635,000
Q2 2020 Aug 11, 2020	SELL	$60.49 - $97.5 $36,717 - $59,182	-607 Reduced 9.52%	5,772 $468,000
Q1 2020 May 08, 2020	BUY	$59.04 - $88.81 $376,616 - $566,518	6,379 New	6,379 $444,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Wrapmanager Inc, based on Form 13F filings with the SEC.

Stay updated on Wrapmanager Inc with notifications on news.